![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bellerophon Therapeutics Inc (CE) | USOTC:BLPH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.056 | 0.00 | 01:00:00 |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 12 | | | |
| | | | 25 | | | |
| | | | 26 | | | |
| | | | 27 | | | |
| | | | 27 | | | |
| | | | 28 | | | |
| | | | 29 | | | |
| | | | A-1 | | | |
| | | | B-1 | | |
Name of Beneficial Owner
|
| |
Shares
Beneficially Owned |
| |
of Shares
Beneficially Owned |
| ||||||
5% Stockholders | | | | | | | | | | | | | |
None. | | | | | | | | | | | | | |
Executive Officers and Directors | | | | | | | | | | | | | |
Peter Fernandes(1)
|
| | | | 110,677 | | | | | | * | | |
Parag Shah(2)
|
| | | | 86,175 | | | | | | * | | |
Martin Dekker
|
| | | | 25,973 | | | | | | * | | |
Naseem Amin(3)
|
| | | | 315,676 | | | | | | 2.6% | | |
Scott Bruder(4)
|
| | | | 38,212 | | | | | | * | | |
Mary Ann Cloyd(5)
|
| | | | 37,757 | | | | | | * | | |
All executive officers and directors as a group (6 persons)
|
| | | | 655,727 | | | | | | 5.2% | | |
1 Year Bellerophon Therapeutics (CE) Chart |
1 Month Bellerophon Therapeutics (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions